Enhanced autocompensating quantum cryptography system.

Appl Opt

IBM Almaden Research Center, 650 Harry Road, San Jose, California 95120-6099, USA.

Published: March 2002

We have improved the hardware and software of our autocompensating system for quantum key distribution by replacing bulk optical components at the end stations with fiber-optic equivalents and implementing software that synchronizes end-station activities, communicates basis choices, corrects errors, and performs privacy amplification over a local area network. The all-fiber-optic arrangement provides stable, efficient, and high-contrast routing of the photons. The low-bit error rate leads to high error-correction efficiency and minimizes data sacrifice during privacy amplification. Characterization measurements made on a number of commercial avalanche photodiodes are presented that highlight the need for improved devices tailored specifically for quantum information applications. A scheme for frequency shifting the photons returning from Alice's station to allow them to be distinguished from backscattered noise photons is also described.

Download full-text PDF

Source
http://dx.doi.org/10.1364/ao.41.001640DOI Listing

Publication Analysis

Top Keywords

privacy amplification
8
enhanced autocompensating
4
autocompensating quantum
4
quantum cryptography
4
cryptography system
4
system improved
4
improved hardware
4
hardware software
4
software autocompensating
4
autocompensating system
4

Similar Publications

Background: In the diagnosis of sexually transmitted infections, there has been a demand for multiple molecular assays to rapidly and simultaneously detect not only pathogens but also drug resistance-associated mutations.

Methods: In this study, we developed a new rapid simultaneous molecular assay for the detection of Neisseria gonorrhoeae, Chlamydia trachomatis, Trichomonas vaginalis, Mycoplasma genitalium, and M. genitalium macrolide (23S rRNA gene, A2058/A2059) and fluoroquinolone (ParC gene, S83I) drug resistance-associated mutations in approximately 35 minutes.

View Article and Find Full Text PDF
Article Synopsis
  • The Wax-CRISPR is an automated diagnostic system designed for at-home testing of multiple sexually transmitted infections (STIs), enhancing women's reproductive health, especially where healthcare access is limited.
  • The technology uses a unique wax phase transition to efficiently isolate and mix different test components on a microfluidic chip, allowing the simultaneous detection of six key pathogens in just 30 minutes.
  • Clinical evaluations show high accuracy, with 96.8% sensitivity and 97.3% specificity, proving its effectiveness even in the hands of untrained users, and promoting a low-cost and user-friendly option for STI testing.
View Article and Find Full Text PDF

The post-processing of quantum key distribution mainly includes error correction and privacy amplification. The error correction algorithms and privacy amplification methods used in the existing quantum key distribution are completely unrelated. Based on the principle of correspondence between error-correcting codes and hash function families, we proposed the idea of time-division multiplexing for error correction and privacy amplification for the first time.

View Article and Find Full Text PDF

High-risk human papillomavirus (HPV) screening is crucial for cervical cancer prevention. However, laboratory-based nucleic acid amplification tests (NAATs) require costly equipment, designated lab space, and skilled personnel. Additionally, cervical swabs collected by healthcare professionals can be inconvenient, uncomfortable, and reduce privacy, limiting broader application and patient compliance.

View Article and Find Full Text PDF
Article Synopsis
  • The study investigates the differences in immune gene expression and survival outcomes between HER2-low and HER2-zero breast cancers, focusing on the tumor immune microenvironment (TME).
  • Comprehensive genomic analysis was conducted on samples from 129 patients with advanced HER2-negative breast cancer, assessing immune-related gene expressions and their correlation with patient survival rates.
  • Results indicate that while there were no significant differences in immune gene expression between HER2-low and HER2-zero cancers, patients with HER2-low tumors exhibited a higher rate of estrogen receptor positivity and significantly better overall survival.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!